AmpC Β-Lactamases

Clinical Microbiology Reviews

Volumn 22, Issue 1, 2009, Pages 161-182

  Jacoby, George A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE AMPC; PORIN; AMPC BETA LACTAMASES; AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE;

ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME STRUCTURE; NONHUMAN; REVIEW; ANTIBIOTIC RESISTANCE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BIOSYNTHESIS; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; HORIZONTAL GENE TRANSFER; HUMAN; MICROBIOLOGY; PLASMID;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CHROMOSOMES, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; HUMANS; PLASMIDS;

EID: 59649115459     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00036-08     Document Type: Review

References (352)

1. Abraham, E. P., and E. Chain. 1940. An enzyme from bacteria able to destroy penicillin. Nature 146:837.
2. Adler, H., L. Fenner, P. Walter, D. Hohler, E. Schultheiss, S. Oezcan, and R. Frei. 2008. Plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland. J. Antimicrob. Chemother. 61:457-458.
3. Ahmad, M., C. Urban, N. Mariano, P. A. Bradford, E. Calcagni, S. J. Projan, K. Bush, and J. J. Rahal. 1999. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin. Infect. Dis. 29:352-355.
4. Ahmed, A. M., and T. Shimamoto. 2008. Emergence of a cefepime- and cefpiro me -resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC β-lactamase. CMY-37. Int. J. Antimicrob. Agents 32:256-261.
5. Alksne, L. E., and B. A. Rasmussen. 1997. Expression of the AsbA1, OXA-12, and AsbM1 β-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon. J. Bacteriol. 179:2006-2013.
6. Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.
7. Ambler, R. P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B 289:321-331.
8. Armand-Lefèvre, L., V. Leflon-Guibout, J. Bredin, F. Barguellil, A. Amor, J. M. Pagès, and M. H. Nicolas-Chanoine. 2003. lmipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production. Antimicrob. Agents Chemother. 47:1165-1168.
9. Avison, M. B., P. M. Bennett, and T. R. Walsh. 2000. β-Lactamase expression in Plesiomonas shigelloides, J. Antimicrob. Chemother. 45:877-880.
10. Avison, M. B., P. Niumsup, K. Nurmahomed, T. R. Walsh, and P. M. Bennett, 2004. Role of the 'cre\blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila β-lactamase regulator, BlrA. J. Antimicrob. Chemother. 53:197-202.
11. Avison, M. B., P. Niumsup, T. R. Walsh, and P. M. Bennett. 2000. Aeromonas hydrophila AmpH and CepH β-lactamases: derepressed expression in mutants of Escherichia coli lacking creB. J. Antimicrob. Chemother. 46:695-702.
12. Avison, M. B., S. Underwood, A. Okazaki, T. R. Walsh, and P. M. Bennett. 2004. Analysis of AmpC β-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients. J. Antimicrob. Chemother. 53:584-591.
13. Babini, G. S., F. Danel, S. D. Munro, P. A, Micklesen, and D. M. Livermore. 1998. Unusual tazobactam-sensitive AmpC β-lactamase from two Escherichia coli isolates. J. Antimicrob. Chemother. 41:115-118.
14. Barlow, M., and B. G. Hall. 2003. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC β-lactamase. Genetics 164: 23-29.
15. Barlow, M., and B. G. Hall. 2002. Origin and evolution of the AmpC β-lactamases of Citrobacter freundii. Antimicrob. Agents Chemother. 46: 1190-1198.
16. Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352-2358.
17. Barnaud, G., Y. Benzerara, J. Gravisse, L. Raskine, M. J. Sanson-Le Pors, R. Labia, and G. Arlet, 2004. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob. Agents Chemother. 48:1040-1042.
18. Barnaud, G., R. Labia, L. Raskine, M. J. Sanson-Le Pors, A. Philippon, and G. Arlet. 2001. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol. Lett. 195:185-190.
19. Batchelor, M., K. L. Hopkins, E. J. Threlfall, F. A. Clifton-Hadley, A. D. Stallwood, R. H, Davies, and E. Liebana. 2005. Characterization of AmpC-mediated resistance in clinical Salmonella isolates recovered from humans during the period 1992 to 2003 in England and Wales. J. Clin. Microbiol. 43:2261-2265.
20. Bauernfeind, A., Y. Chong, and S. Schweighart, 1989. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
21. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC β-lactamase, ACC-1. produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924-1931.
22. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H, Giamarellou. 1996. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221-224.
23. CMY-1 gene and its relationship with other β-lactamase genes. Antimicrob. Agents Chemother. 40:1926-1930.
24. Baumann, M., H. Simon, K. H, Schneider, H. J. Danneel, U. Küster, and F. Giffhorn. 1989. Susceptibility of Rhodobacter sphaeroides to β-lactam antibiotics: isolation and characterization of a periplasmic β-lactamase (cephalosporinase). J. Bacteriol. 171:308-313.
25. Bauvois, C., A. S. Ibuka, A. Celso, J. Alba, Y. Ishii, J. M. Frère, and M. Galleni. 2005. Kinetic properties of four plasmid-mediated AmpC β-lactamases. Antimicrob. Agents Chemother. 49:4240-4246.
26. Beceiro, A., F. J. Pérez-Llarena, A. Pérez, M. Tomás, A. Fernández, S. Mallo, R. Villanueva, and G. Bou. 2007. Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyi. J. Antimicrob. Chemother. 59:996-1000.
27. Beckstrom-Sternberg, S. M., R. K. Auerbach, S. Godbole, J. V, Pearson, J. S. Beckstrom-Sternberg, Z. Deng, C. Munk, K. Kubota, Y. Zhou, D. Bruce, J. Noronha, R. H. Scheuermann, A. Wang, X. Wei, J. Wang, J. Hao, D. M. Wagner, T. S. Brettin, N. Brown, P. Gilna, and P. S. Keim. 2007. Complete genomic characterization of a pathogenic A.II strain of Francisella tularensis subspecies tularensis. PLoS ONE 2:e947.
28. Beesley, T., N, Gascoyne, V. Knott-Hunziker, S. Petursson, S, G. Waley, B. Jaurin, and T. Grundstrom. 1983. The inhibition of class C β-lactamases by boronic acids. Biochem. J. 209:229-233.
29. Bell, J. M., M. Chitsaz, J. D. Turnidge, M. Barton, L. J. Walters, and R. N. Jones. 2007. Prevalence and significance of a negative extended-spectrum β-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific surveillance program. J. Clin. Microbiol. 45:1478-1482.
30. Bellais, S., L. Poirel, N. Fortineau, J. W. Decousser, and P. Nordmann. 2001. Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A β-lactamase from Rahnella aquatilis. Antimi-crob. Agents Chemother. 45:2965-2968.
31. Bergström, S., F. P. Lindberg, O. Olsson, and S. Normark. 1983. Comparison of the overlapping frd and ampC operons of Escherichia coli with the corresponding DNA sequences in other gram-negative bacteria. J. Bacte-riol. 155:1297-1305.
32. Bergstrom, S., and S. Normark. 1979. β-Lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal β-lactamase. Antimicrob. Agents Chemother. 16:427-433.
33. Bergström, S., O. Olsson, and S. Normark. 1982. Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria. J. Bacteriol. 150:528-534.
34. Bidet, P., B. Burghoffer, V. Gautier, N. Brahimi, P. Mariani-Kurkdjian, A. El-Ghoneimi, E. Bingen, and G. Arlet. 2005. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob. Agents Chemother. 49:3562-3565.
35. Black, J. A., E. S. Moland, and K. S. Thomson. 2005. AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases. J. Clin. Microbiol. 43:3110-3113.
36. Black, J. A., K. S. Thomson, J. D. Buynak, and J. D. Pitout. 2005. Evaluation of β-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC β-lactamases in well-characterized clinical strains of Klebsiella spp. J. Clin. Microbiol. 43:4168-4171.
37. Black, J. A, K. S. Thomson, and J, D. Pitout. 2004. Use of β-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC β-lactamases. J. Clin. Microbiol. 42:2203-2206.
38. Bolmström, A., A. Engelhardt, L. Bylund, P. Ho, and Å. Karlsson. 2006. Evaluation of two new Etest strips for AmpC detection, abstr. D-0451. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother.
39. Bou, G., and J. Martinez-Beltran. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetohacter baumannii. Antimicrob. Agents Chemother. 44:428-432.
40. Bradford, P. A., P. J. Petersen, I. M. Fingerman, and D. G. White. 1999. Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease. J. Antimicrob. Chemother. 44:607-610.
41. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase. and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
42. Bratu, S., D. Landman, D. A. Martin, C. Georgescu, and J. Quale. 2008. Correlation of antimicrobial resistance with β-lactamases. the OmpA-like porin, and efflux pumps in clinical isolates of Acinetohacter baumannii endemic to New York City. Antimicrob. Agents Chemother. 52:2999-3005.
43. Brenwald, N. P., J. Andrews, and A. P. Fraise. 2006. Activity of mecillinam against AmpC β-lactamase-producing Escherichia coli. J. Antimicrob. Chemother. 58:223-224.
44. Brenwald, N. P., G. Jevons, J. Andrews, L. Ang, and A. P. Fraise. 2005. Disc methods for detecting AmpC β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae. J. Antimicrob. Chemother. 56: 600-601.
45. Bulychev, A., and S. Mobashery. 1999. Class C β-lactamases operate at the diffusion limit for turnover of their preferred cephalosporin substrates. Antimicrob. Agents Chemother. 43:1743-1746.
46. Burman, L. G., J. T. Park, E. B. Lindström, and H. G. Boman. 1973. Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase. J. Bacteriol. 116:123-130.
47. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
48. Bush, K., C. Macalintal, B. A. Rasmussen, V. J. Lee, and Y. Yang. 1993. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob. Agents Chemother. 37:851-858.
49. Cao, V. T., G. Arlet, B. M. Ericsson, A. Tammelin, P. Courvalin, and T. Lambert. 2000. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46:895-900.
50. Carattoli, A., F. Tosini, W. P. Giles, M. E. Rupp, S. H. Hinrichs, F. J. Angulo, T. J. Barrett, and P. D. Fey. 2002. Characterization of plasmids carrying CMY-2 from expanded-spectmm cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob. Agents Chemother. 46:1269-1272.
51. Caroff, N., E. Espaze, I. Berard, H. Richet, and A. Reynaud. 1999. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production. FEMS Microbiol. Lett. 173:459-465.
52. Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of - 42 and - 32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J. Antimicrob. Chemother. 45:783-788.
53. Cavallo, J. D., R. Fabre, F. Leblanc, M. H. Nicolas-Chanoine, and A. Thabaut. 2000. Antibiotic susceptibility and mechanisms of β-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre studv (1996). J. Antimicrob. Chemother. 46:133-136.
54. Chen, Y., G. Minasov, T. A. Roth, F. Prati, and B. K. Shoichet. 2006. The deacylation mechanism of AmpC β-lactamase at ultrahigh resolution. J. Am. Chem. Soc. 128:2970-2976.
55. Chen, Y. T., T. L. Lauderdale, T. L. Liao, Y. R. Shiau, H. Y. Shu, K. M. Wu, J. J. Yan, I. J. Su, and S. F. Tsai. 2007. Sequencing and comparative genomic analysis of pK29. a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 β-lactamases in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 51:3004-3007.
56. Chien, M., I. Morozova, S. Shi, H. Sheng, J. Chen, S. M. Gomez, G. Asamani, K. Hill, J. Nuara, M. Feder, J. Rineer, J. J. Greenberg, V. Steshenko, S. H. Park, B. Zhao, E. Teplitskaya, J. R. Edwards, S. Pampou, A. Georghiou, I. C. Chou, W. Iannuccilli, M. E. Ulz, D. H. Kim, A. Geringer-Sameth, C. Goldsberry, P. Morozov, S. G. Fischer, G. Segal, X. Qu, A. Rzhetsky, P. Zhang, E. Cayanis, P. J. De Jong, J. Ju, S. Kalachikov, H. A. Shuman, and J. J. Russo. 2004. The genomic sequence of the accidental pathogen Legionella pneumophila. Science 305:1966-1968.
57. Choi, S. H., J. E. Lee, S. J. Park, S. O. Lee, J. Y Jeong, M. N. Kim, J. H. Woo, and Y. S. Kim. 2008. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: implications for antibiotic use. Antimicrob. Agents Chemother. 52: 995-1000.
58. Chow, J. W., M. J. Fine, D. M. Shlaes, J. P. Quinn, D. C. Hooper, M. P. Johnson, R. Ramphal, M. M. Wagener, D. K. Miyashiro, and V. L. Yu. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
59. Chow, J. W., and D. M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob. Chemother. 28:499-504.
60. Cole, S. T. 1987. Nucleotide sequence and comparative analysis of the frd operon encoding the fumarate reductase of Proteus vulgaris. Extensive sequence divergence of the membrane anchors and absence of an frd-linked ampC cephalosporinase gene. Eur. J. Biochem. 167:481-488.
61. Corvee, S., N. Caroff, E. Espaze, C. Giraudeau, H. Drugeon, and A. Reynaud. 2003. AmpC cephalosporinase hyperproduction in Acinetohacter baumannii clinical strains. J. Antimicrob. Chemother. 52:629-635.
62. Corvee, S., A. Prodhomme, C. Giraudeau, S. Dauvergne, A. Reynaud, and N. Caroff. 2007. Most Escherichia coli strains overproducing chromosomal AmpC β-lactamase belong to phylogenetic group A. J. Antimicrob. Chemother. 60:872-876.
63. Cosgrove, S. E., K. S. Kaye, G. M. Eliopoulous, and Y Carmeli. 2002. Health and economic outcomes of the emergence of third-gene ration cephalosporin resistance in Enterobacter species. Arch. Intern. Med. 162:185-190.
64. Coudron, P. E. 2005. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J. Clin. Microbiol. 43:4163-4167.
65. Coudron, P. E., N. D. Hanson, and M. W. Climo. 2003. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases. J. Clin. Microbiol. 41:772-777.
66. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38:1791-1796.
67. Crichlow, G. V., A. P. Kuzin, M. Nukaga, K. Mayama, T. Sawai, and J. R. Knox. 1999. Structure of the extended-spectrum class C β-lactamase of Enterobacter cloacae GO. a natural mutant with a tandem tripeptide insertion. Biochemistiy 38:10256-10261.
68. Curtis, N. A. C., R. L. Eisenstadt, C. Rudd, and A. J. White. 1986. Inducible type I β-lactamases of gram-negative bacteria and resistance to β-lactam antibiotics. J. Antimicrob. Chemother. 17:51-61.
69. D'Andrea, M. M., E. Nucleo, F. Luzzaro, T. Giani, R. Migliavacca, F. Vailati, V. Kroumova, L. Pagani, and G. M. Rossolini. 2006. CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob. Agents Chemother. 50:618-624.
70. da Silva Dias, R. C., A. A. Borges-Neto, G. I. D'Almeida Ferraiuoli, M. P. de-Oliveira, L. W. Riley, and B. M. Moreira. 2008. Prevalence of AmpC and other β-lactamases in enterobacteria at a large urban university hospital in Brazil. Diagn. Microbiol. Infect. Dis. 60:79-87.
71. de Champs, C., C. Henquell, D. Guelon, D. Sirot, N, Gazuy, and J. Sirot. 1993. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J. Clin. Microbiol. 31:123-127.
72. Decousser, J. W., L. Poirel, and P. Nordmann. 2001. Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens. Antimicrob. Agents Chemother. 45:3595-3598.
73. Deshpande, L. M., R. N. Jones, T.R. Fritsche, and H. S. Sader. 2006. Occurrence of plasmidic AmpC type β-lactamase-media ted resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). Int. J. Antimicrob. Agents 28:578-581.
74. Devasia, R. A., J. K. Varma, J. Whichard, S. Gettner, A. B. Cronquist, S. Hurd, S. Segler, K. Smith, D. Hoefer, B. Shiferaw, F. J. Angulo, and T. F. Jones. 2005. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. Microb. Drug Resist. 11:371-377.
75. Ding, H., Y. Yang, Q. Lu, Y. Wang, Y. Chen, L. Deng, A. Wang, Q. Deng, H. Zhang, C. Wang, L. Liu, X. Xu, L. Wang, and X. Shen. 2008. The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur. J. Clin. Microbiol. Infect. Dis. 27:915-921.
76. Doi, Y., and D. L. Paterson. 2007. Detection of plasmid-mediated class C β-lactamases. Int. J. Infect. Dis. 11:191-197.
77. Doi, Y., J. Wachino, M. Ishiguro, H. Kurokawa, K. Yamane, N. Shibata, K. Shibayama, K. Yokoyama, H. Kato, T. Yagi, and Y. Arakawa. 2004. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48:2652-2658.
78. ACC-1 β-lactamase gene in Enterobacteriaceae isolates. Antimicrob. Agents Chemother. 50:4177-4181.
79. Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frère. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins 25:473-485.
80. Dunne, E. F., P. D. Fey, P. Kludt, R. Reporter, F. Mostashari, P. Shillam, J. Wicklund, C. Miller, B. Holland, K. Stamey, T. J. Barrett, J. K. Rasheed, F. C. Tenover, E. M. Ribot, and F. J. Angulo. 2000. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 284:3151-3156.
81. Egorova, S., M. Timinouni, M. Demartin, S. A. Granier, J. M. Whichard, Y. Sangal, L. Fabre, A, Delauné, M. Pardos, Y. Millemann, E. Espié, M. Achtman, P. A. Grimont, and F. X. Weill. 2008. Ceftriaxone-resistant Salmonella enterica serotype Newport. France. Emerg. Infect. Dis. 14:954-957.
82. Empel, J., A. Baraniak, E. Literacka, A. Mrowka, J, Fiett, E. Sadowy, W. Hryniewicz, and M. Gniadkowski. 2008. Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob. Agents Chemother. 52:2449-2454.
83. Engelhardt, A., A. Yusof, P. Ho, K. Sjöström, and C. Johansson. 2008. Evaluation of a new Etest strip for AmpC detection using a large collection of genotypically characterized strains, abstr. D-280. Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother.
84. Eriksson-Grennberg, K. G. 1968. Resistance of Escherichia coli to penicillins. II. An improved mapping of the ampA gene. Genet. Res. 12:147-156.
85. Eriksson-Grennberg, K. G., H. G. Boman, J. A. Jansson, and S. Thorén. 1965. Resistance of Escherichia coli to penicillins. I. Genetic study of some ampicillin-resistant mutants. J. Bacteriol. 90:54-62.
86. Fakioglu, E., A. M. Queenan, K. Bush, S. G. Jenkins, and B. C. Herold. 2006. AmpC β-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge. J. Perinatol. 26:515-517.
87. Farrar, W. E, Jr., and N. M. O'Dell. 1976. β-Lactamase activity in Chro-mobacterium violaceum. J. Infect. Dis. 134:290-293.
88. Feller, G., Z. Zekhnini, J. Lamotte-Brasseur, and C. Gerday. 1997. Enzymes from cold-adapted microorganisms. The class C β-lactamase from the antarctic psychrophile Psychrobacter immobilis A5. Eur. J. Biochem. 244:186-191.
89. Fey, P. D., T. J. Safranek, M. E. Rupp, E. F. Dunne, E. Ribot, I. P. C., P. A. Bradford, F. J. Angulo, and S. H. Hinrichs. 2000. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342:1242-1249.
90. Fihman, V., M. Rottman, Y. Benzerara, F. Delisle, R. Labia, A. Philippon, and G. Arlet. 2002. BUT-1: a new member in the chromosomal inducible class C β-lactamases family from a clinical isolate of Buttiauxella sp. FEMS Microbiol. Lett. 213:103-111.
91. Fitoussi, F., G. Arlet, P. A. Grimont, P. Lagrange, and A. Philippon. 1995. Escherichia hermannii: susceptibility pattern to β-lactams and production of β-lactamase. J. Antimicrob. Chemother. 36:537-543.
92. Flores, A. R., L. M. Parsons, and M. S. Pavelka, Jr. 2005. Genetic analysis of the β-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to β-lactam antibiotics. Microbiology 151:521-532.
93. Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210.
94. Forward, K. R., B. M. Willey, D. E. Low, A. McGeer, M. A. Kapala, M. M. Kapala, and L. L. Burrows. 2001. Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals. Diagn. Microbiol. Infect. Dis. 41:57-63.
95. Fosse, T., C. Giraud-Morin, I. Madinier, and R. Labia. 2003. Sequence analysis and biochemical characterisation of chromosomal CAV-1 (Aero-monas caviae), the parental cephalosporinase of plasmid-mediated AmpC 'FOX' cluster. FEMS Microbiol. Lett. 222:93-98.
96. Franceschini, N., L. Boschi, S. Pollini, R. Herman, M. Perilli, M. Galleni, J. M. Frère, G. Amicosante, and G. M. Rossolini. 2001. Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: molecular class D β-lactamase with unusual properties. Antimicrob. Agents Chemother. 45:3509-3516.
97. Franceschini, N., M. Galleni, J. M. Frère, A. Oratore, and G. Amicosante. 1993. A class-A β-lactamase from Pseudomonas stutzeri that is highly active against monobactams and cefotaxime. Biochem. J. 292:697-700.
98. Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable β-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 39:85-87.
99. Galleni, M., G. Amicosante, and J. M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Cephalosporins and other β-lactam compounds. Biochem. J. 255:123-129.
100. Galleni, M., and J. M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Penicillins. Biochem. J. 255:119-122.
101. Galleni, M., F. Lindberg, S. Normark, S. Cole, N. Honore, B. Joris, and J. M. Frere. 1988. Sequence and comparative analysis of three Enterobacter cloacae ampC β-lactamase genes and their products. Biochem. J. 250:753-760.
102. Gates, M. L., C. C. Sanders, R. Y. Goering, and W. E. Sanders, Jr. 1986. Evidence for multiple forms of type I chromosomal β-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 30:453-457.
103. Gazouli, M., M. E. Kaufmann, E. Tzelepi, H. Dimopoulou, O. Paniara, and L. S. Tzouvelekis. 1997. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J. Clin. Microbiol. 35:508-510.
104. Gazouli, M., L. S. Tzouvelekis, A. C. Yatopoulos, and E. Tzelepi. 1998. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase. J. Antimicrob. Chemother. 42:419-425.
105. CMY-2 from multiple Salmonella plasmid backbones. Antimicrob. Agents Chemother. 48:2845-2852.
106. Girlich, D., T. Naas, S. Bellais, L. Poirel, A. Karim, and P. Nordmann. 2000. Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob. Agents Chemother. 44:1470-1478.
107. Girlich, D., T. Naas, S. Bellais, L. Poirel, A. Karim, and P. Nordmann. 2000. Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance pheno-types. Antimicrob. Agents Chemother. 44:3220-3223.
108. Glupczynski, Y., T. D. Huang, C. Berhin, G. Claeys, M. Delmée, L. Ide, G. Ieven, D. Pierard, H. Rodriguez-Villalobos, M. Struelens, and J. Vaneldere. 2007. In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units. Eur. J. Clin. Microbiol. Infect. Dis. 26:777-783.
109. Gonzalez Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
110. Goodner, B., G. Hinkle, S. Gattung, N. Miller, M. Blanchard, B. Qurollo, B. S. Goldman, Y. Cao, M. Askenazi, C. Hailing, L. Mullin, K. Houmiel, J. Gordon, M. Vaudin, O. Iartchouk, A. Epp, F. Liu, C. Wollam, M. Allinger, D. Doughty, C. Scott, C. Lappas, B. Markelz, C. Flanagan, C. Crowell, J. Gurson, C. Lomo, C. Sear, G. Strub, C. Cielo, and S. Slater. 2001. Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science 294:2323-2328.
111. Gould, V. C., A. Okazaki, and M. B. Avison. 2006. β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J. Antimicrob. Chemother. 57: 199-203.
112. Gray, J. T., L. L. Hungerford, P. J. Fedorka-Cray, and M. L. Headrick. 2004. Extended-spectrum-cephalosporin resistance in Salmonella enterica isolates of animal origin. Antimicrob. Agents Chemother. 48:3179-3181.
113. Gupta, A., J. Fontana, C. Crowe, B. Bolstorff, A. Stout, S. Van Duyne, M. P. Hoekstra, J. M. Whichard, T. J. Barrett, and F. J. Angulo. 2003. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J. Infect. Dis. 188:1707-1716.
114. Gutiérrez, O., C. Juan, E. Cercenado, F. Navarro, E. Bouza, P. Coll, J. L. Pérez, and A. Oliver. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335.
115. Haldorsen, B., B. Aasnaes, K. H. Dahl, A. M. Hanssen, G. S. Simonsen, T. R. Walsh, A. Sundsfjord, and E. W. Lundblad. 2008. The AmpC phe-notype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J. Antimicrob. Chemother. 62:694-702.
116. Hall, B. G., and M. Barlow. 2004. Evolution of the serine β-lactamases: past, present and future. Drug Resist. Updates 7:111-123.
117. Hanson, N. D., E. S. Moland, S. G. Hong, K. Propst, D. J. Novak, and S. J. Cavalieri. 2008. Surveillance of community-based reservoirs reveals the presence of CTX-M. imported AmpC., and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 52:3814-3816.
118. Hanson, N. D., and C. C. Sanders. 1999. Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Curr. Pharm. Des. 5:881-894.
119. Hanson, N. D., K. S. Thomson, E. S. Moland, C. C. Sanders, G. Berthold, and R. G. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380.
120. Hayes, M. V., C. J. Thomson, and S. G. Amyes. 1994. Three beta-lactamases isolated from Aeromonas salmonicida, including a carbapenemase not detectable by conventional methods. Eur. J. Clin. Microbiol. Infect. Dis. 13:805-811.
121. Henderson, T. A., K. D. Young, S. A. Denome, and P. K. Elf. 1997. AmpC and AmpH, proteins related to the class C β-lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli. J. Bacteriol. 179: 6112-6121.
122. Héritier, C., L. Poirel, and P. Nordmann. 2006. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:123-130.
123. Héritier, C., L. Poirel, and P. Nordmann. 2004. Genetic and biochemical characterization of a chromosome-encoded carbapenem-hydrolyzing Ambler class D β-lactamase from Shewanella algae. Antimicrob. Agents Chemother. 48:1670-1675.
124. Hernández-Allés, S., V. J. Benedí, L. Martínez-Martínez, A. Pascual, A. Aguilar, J. M. Tomás, and S. Albertí. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.
125. Hernández-Allés, S, M. Conejo, A. Pascual, J. M. Tomás, V. J. Benedí, and L. Martínez-Martínez. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46:273-277.
126. Hidri, N., G. Barnaud, D. Decré, C. Cerceau, V. Lalande, J. C. Petit, R. Labia, and G. Arlet. 2005. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC β-lactamase of a Serratia marcescens clinical isolate. J. Antimicrob. Chemother. 55:496-499.
127. Higgins, C. S., M. B. Avison, L. Jamieson, A. M. Simm, P. M. Bennett, and T. R. Walsh. 2001. Characterization, cloning and sequence analysis of the inducible Ochrobactrum anthropi AmpC β-lactamase. J. Antimicrob. Chemother. 47:745-754.
128. Hirakawa, H., K. Nishino, J. Yamada, T. Hirata, and A. Yamaguchi. 2003. β-Lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J. Antimicrob. Chemother. 52:576-582.
129. Honoré, N., M. H. Nicolas, and S. T. Cole. 1986. Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J. 5:3709-3714.
130. Hope, R., M. Warner, N. A. Potz, E. J. Fagan, D. James, and D. M. Livermore. 2006. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England. J. Antimicrob. Chemother. 58:1312-1314.
131. Hopkins, J. M., and K. J. Towner. 1990. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J. Antimicrob. Chemother. 25:49-55.
132. Hopkins, K. L., M. J. Batchelor, E. Liebana, A. P. Deheer-Graham, and E. J. Threlfall. 2006. Characterisation of CTX-M and ampC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales. Int. J. Antimicrob. Agents 28:180-192.
133. Hopkins, K. L., A. Deheer-Graham, E. Karisik, M. J. Batchelor, E. Liebana, and E. J. Threlfall. 2006. New plasmid-mediated AmpC β-lactamase (CMY-21) in Escherichia coli isolated in the UK. Int. J. Antimicrob. Agents 28:80-82.
134. Horii, T., Y, Arakawa, M. Ohta, S, Ichiyama, R, Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type β-lactamase isolated from Kleb-siella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990.
135. Hossain, A., M. D. Reisbig, and N. D, Hanson. 2004. Plasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhimurium. J. Antimicrob. Chemother. 53: 964-970.
136. Huang, I. F., C., H. Chiu, M. H. Wang, C. Y. Wu, K, S. Hsieh, and C. C. Chiou. 2005. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC β-lactamase resistance in S. sonnei. J. Clin. Microbiol. 43:2608-2612.
137. Hujer, K. M., N. S. Hamza, A. M. Hujer, F. Perez, M. S. Helfand, C. R. Bethel, J. M. Thomson, V. E. Anderson, M. Barlow, L. B. Rice, F. C. Tenover, and R, A. Bonomo. 2005. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase. ADC-7 β-lactamase: defining a unique family of class C enzymes. Antimicrob. Agents Chemother. 49:2941-2948.
138. Humeniuk, C., G. Arlet, V. Gautier, P. Grimont, R. Labia, and A. Philippon. 2002. β-Lactamases of Kluyvera ascorbata. probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 46: 3045-3049.
139. Jacobs, C., J. M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in gram-negative bacteria. Cell 88:823-832.
140. Jacobs, C., L, Huang, E. Bartowsky, S. Normark, and J, T. Park. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effector for β-lactamase induction. EMBO J. 13:4684-4694.
141. Jacoby, G. A., D. M. Mills, and N. Chow. 2004. Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:3203-3206.
142. Jacoby, G. A., and J. Tran. 1999. Sequence of the MIR-1 β-lactamase gene. Antimicrob. Agents Chemother. 43:1759-1760.
143. Jacoby, G. A., K. E. Walsh, and V. J. Walker. 2006. Identification of extended-spectrum, AmpC., and carbapenem-hydrolyzing β-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J. Clin. Microbiol. 44:1971-1976.
144. Jaurin, B., and T. Grundström. 1981. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. USA 78:4897-4901.
145. Jaurin, B., T. Grundström, T. Edlund, and S. Normark. 1981. The E. coli β-lactamase attenuator mediates growth rate-dependent regulation. Nature 290:221-225.
146. Jaurin, B., and S. Normark. 1983. Insertion of IS2 creates a novel ampC promoter in Escherichia coli. Cell 32:809-816.
147. Jones, R. N., J. T. Kirby, and P. R. Rhomberg. 2008. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance. Diagn. Microbiol. Infect. Dis. 61:203-213.
148. Joris, B., F. De Meester, M. Galleni, S. Masson, J. Dusart, J. M. Frère, J. Van Beeumen, K. Bush, and R. Sykes. 1986. Properties of a class C β-lactamase from Serratia marcescens. Biochem. J. 239:581-586.
149. Joris, B., P. Ledent, O. Dideberg, E. Fonzé, J. Lamotte-Brasseur, J. A. Kelly, J. M. Ghuysen, and J. M. Frère. 1991. Comparison of the sequences of class A β-lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob. Agents Chemother. 35:2294-2301.
150. Juan, C., M. D. Macia, O. Gutierrez, C. Vidal, J. L. Perez, and A. Oliver. 2005. Molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeniginosa clinical strains. Antimicrob. Agents Chemother. 49:4733-4738.
151. Juan, C., B. Moyá, J. L. Pérez, and A. Oliver. 2006. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level β-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother. 50:1780-1787.
152. ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob. Agents Chemother. 50:3396-3406.
153. Kaneko, K., R. Okamoto, R. Nakano, S. Kawakami, and M. Inoue. 2005. Gene mutations responsible for overexpression of AmpC β-lactamase in some clinical isolates of Enterobacter cloacae. J. Clin. Microbiol. 43:2955-2958.
154. Kang, C. I., H. Pai, S. H. Kim, H. B. Kim, E. C. Kim, M. D. Oh, and K. W. Choe. 2004. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase. J. Antimicrob. Chemother. 54:1130-1133.
155. CMY-1 β-lactamase gene in Escherichia coli and Salmonella enterica plasmids. Antimicrob. Agents Chemother. 50:1590-1593.
156. Kaye, K. S., S. Cosgrove, A. Harris, G. M. Eliopoulos, and Y. Carmeli. 2001. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob. Agents Chemother. 45:2628-2630.
157. Kazmierczak, A., X. Cordin, J. M. Duez, E. Siebor, A. Pechinot, and J. Sirot. 1990. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria. J. Int. Med. Res. 18(Suppl. 4):67D-77D.
158. Kim, J. Y., H. I. Jung, Y. J. An, J. H. Lee, S. J. Kim, S. H. Jeong, K. J. Lee, P. G. Suh, H. S. Lee, S. H. Lee, and S. S. Cha. 2006. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase. Mol. Microbiol. 60:907-916.
159. Kimura, H., M. Izawa, and Y. Sumino. 1996. Molecular analysis of the gene cluster involved in cephalosporin biosynthesis from Lysobacter lactamgenus YK90. Appl. Microbiol. Biotechnol. 44:589-596.
160. Kitzis, M. D., B. Ferre, A. Coutrot, J. F. Acar, and L. Gutmann. 1989. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 8:783-788.
161. Knott-Hunziker, V., S. Petursson, G. S. Jayatilake, S. G. Waley, B. Jaurin, and T, Grundström. 1982. Active sites of β-lactamases. Biochem. J. 201: 621-627.
162. Knox, J. R., P. C. Moevrs, and J. M. Frere. 1996. Molecular evolution of bacterial β-lactam resistance. Chem. Biol. 3:937-947.
163. Kohler, T., M. Michea-Hamzehpour, S. F. Epp, and J- C. Pechere. 1999. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux svstems. Antimicrob. Agents Chemother. 43: 424-427.
164. Kong, K. F., S. R. Jayawardena, S. D. Indulkar, A. Del Puerto, C. L. Koh, N. Hoiby, and K. Mathee. 2005. Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB β-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob. Agents Chemother. 49:4567-4575.
165. Kuga, A., R. Okamoto, and M. Inoue. 2000. ampR gene mutations that greatly increase class C β-lactamase activity in Enterobacter cloacae. Antimicrob. Agents Chemother. 44:561-567.
166. CTX-M of Kluyvera ascorbata. Antimicrob. Agents Chemother. 50:1282-1286.
167. Lau, S. K., P. L. Ho, M. W. Li, H. W. Tsoi, R. W. Yung, P. C. Woo, and K. Y. Yuen. 2005. Cloning and characterization of a chromosomal class C β-lactamase and its regulatory gene in Laribacter hongkongensis. Antimicrob. Agents Chemother. 49:1957-1964.
168. Lee, E. H., M. H. Nicolas, M. D. Kitzis, G. Pialoux, E. Collatz, and L. Gutmann. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob. Agents Chemother. 35:1093-1098.
169. Lee, K., S. G. Hong, Y. J. Park, H. S. Lee, W. Song, J. Jeong, D. Yong, and Y. Chong. 2005. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC β-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae. Diagn. Microbiol. Infect. Dis. 53:319-323.
170. Lee, K., M. Lee, J. H. Shin, M. H. Lee, S. H. Kang, A. J. Park, D. Yong, and Y. Chong. 2006. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb. Drug Resist. 12:44-49.
171. Lee, K., D. Yong, Y. S. Choi, J. H. Yum, J. M. Kim, N. Woodford, D. M. Livermore, and Y. Chong. 2007. Reduced imipenem susceptibility in Klebsiella pneumoniae. clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int. J. Antimicrob. Agents 29:201-206.
172. CMY-10 a novel, plasmid-encoded AmpC-type β-lactamase gene in a clinical isolate of Enterobacter aerogenes. J. Appl. Microbiol. 95:744-752.
173. Lee, S. H., J. H. Lee, M. J. Heo, L K. Bae, S. H. Jeong, and S. S. Cha. 2007. Exact location of the region responsible for the extended substrate spectrum in class C β-lactamases. Antimicrob. Agents Chemother. 51:3778-3779.
174. Li, Y., Q. Li, Y Du, X. Jiang, J. Tang, J. Wang, G. Li, and Y. Jiang. 2008. Prevalence of plasmid-mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-type AmpC β-lactamase resistance in China. J. Clin. Microbiol. 46:1317-1321.
175. Liassine, N., S. Madec, B. Ninet, C. Metral, M. Fouchereau-Peron, R. Labia, and R. Auekenthaler. 2002. Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A β-lactamase HugA and its LysR-type regulatory protein HugR. Antimicrob. Agents Chemother. 46:216-219.
176. Liebana, E., M. Gibbs, C. Clouting, L. Barker, F. A. Clifton-Hadley, E. Pleydell, B. Abdalhamid, N. D. Hanson, L. Martin, C. Poppe, and R. H. Davies. 2004. Characterization of β-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb. Drug Resist. 10:1-9.
177. Lin, J. W., S. F. Weng, Y. F. Chao, and Y. T. Chung. 2005. Characteristic analysis of the ampC gene encoding β-lactamase from Photobacterium phosphoreum. Biochem. Biophys. Res. Commun. 326:539-547.
178. Linberg, F., and S. Normark. 1986. Sequence of the Citrobacter freundii OS60 chromosomal ampC β-lactamase gene. Eur. J. Biochem. 156:441-445.
179. Lindquist, S., K. Weston-Hafer, H. Schmidt, C. Pul, G. Korfmann, J. Erickson, C. Sanders, H. H. Martin, and S. Normark. 1993. AmpG, a signal transducer in chromosomal β-lactamase induction. Mol. Microbiol. 9:703-715.
180. Linström, E. B., H. G. Boman, and B. B. Steele. 1970. Resistance of Escherichia coli to penicillins. VI. Purification and characterization of the chromosomally mediated penicillinase present in ampA-containing strains. J. Bacteriol. 101:218-231.
181. Lister, P. D., V. M. Gardner, and C. C. Sanders. 1999. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. Antimicrob. Agents Chemother. 43:882-889.
182. Literacka, E., J. Empel, A. Baraniak, E. Sadowy, W. Hryniewicz, and M. Gniadkowski. 2004. Four variants of the Citrobacter freundii AmpC-type cephalosporinases. including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob. Agents Chemother. 48:4136-4143.
183. Liu, Y F., J. J. Yan, W. C. Ko, S. H. Tsai, and J. J. Wu. 2008. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 61:1020-1023.
184. Livermore, D. M. 1987. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur. J. Clin. Microbiol. 6:439-445.
185. Livermore, D. M. 1992. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2046-2048.
186. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34: 634-640.
187. Livermore, D. M., R. Hope, E. J. Fagan, M. Warner, N. Woodford, and N. Potz. 2006. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England. J. Antimicrob. Chemother. 57:1012-1014.
188. Livermore, D. M., and N. Woodford. 2006. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14: 413-420.
189. Livermore, D. M., and Y. J. Yang. 1987. β-Lactamase lability and inducer power of newer β-lactam antibiotics in relation to their activity against β-lactamase-inducibility mutants of Pseudomonas aeruginosa. J. Infect. Dis. 155:775-782.
190. Lobkovsky, E., P. C. Moews, H. Liu, H. Zhao, J. M. Frere, and J. R. Knox. 1993. Evolution of an enzyme activity: crystallographic structure at 2-Å resolution of cephalosporinase from the ampC gene ofEnterobacter cloacae P99 and comparison with a class A penicillinase. Proc. Natl. Acad. Sci. USA 90:11257-11261.
191. Mahlen, S. D., S. S. Morrow, B. Abdalhamid, and N. D. Hanson. 2003. Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. J. Antimicrob. Chemother. 51:791-802.
192. Mainardi, J. L., P. Mugnier, A. Coutrot, A. Buu-Hoï, E. Collatz, and L. Gutmann. 1997. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob. Agents Chemother. 41:2352-2354.
193. Mammeri, H., F. Eb, A. Berkani, and P. Nordmann. 2008. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 61:498-503.
194. Mammeri, H., H. Nazic, T. Naas, L. Poirel, S. Leotard, and P. Nordmann. 2004. AmpC β-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 48:4050-4053.
195. Mammeri, H., P. Nordmann, A. Berkani, and F. Eb. 2008. Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol. Lett. 282:238-240.
196. Mammeri, H., L. Poirel, P. Bemer, H. Drugeon, and P. Nordmann. 2004. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 48:716-720.
197. Mammeri, H., L. Poirel, N, Fortineau, and P. Nordmann. 2006. Naturally occurring extended-spectrum cephalosporinases in Escherichia coli. Antimicrob. Agents Chemother. 50:2573-2576.
198. Mammeri, H., L. Poirel, H. Nazik, and P. Nordmann. 2006. Cloning and functional characterization of the Ambler class C β-lactamase of Yersinia ruckeri. FEMS Microbiol. Lett. 257:57-62.
199. Mammeri, H., L, Poirel, and P. Nordmann. 2007. Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J. Antimicrob. Chemother. 60:490-494.
200. Manchanda, V., and N. P. Singh. 2003. Occurrence and detection of AmpC β-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Gum Tegh Bahadur Hospital, Delhi, India. J. Antimicrob. Chemother. 51:415-418.
201. Martínez-Martínez, L., M. C. Conejo, A. Pascual, S. Hernández-Allés, S. Ballesta, E. Ramírez De Arellano-Ramos, V. J. Benedí, and E. J. Perea. 2000. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamase and showing altered porin profiles. Antimicrob. Agents Chemother. 44:2534-2536.
202. Martínez-Martínez, L., S. Hernández-Allés, S. Albertí, J. M Tomás, V, J. Benedi, and G. A. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expandedspectrum cephalosporins. Antimicrob. Agents Chemother. 40:342-348.
203. Martínez-Martínez, L., A. Pascual, S. Hernández-Allés, D. Alvarez-Díaz, A. I. Suárez, J. Tran, V. J. Benedí, and G. A. Jacoby. 1999. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669-1673.
204. Matagne, A., A. M. Misselyn-Bauduin, B. Joris, T. Erpicum, B. Granier, and J. M. Frère. 1990. The diversity of the catalytic properties of class A β-lactamases. Biochem. J. 265:131-146.
205. Matsubara, N., A. Yotsuji, K. Kumano, M. Inoue, and S. Mitsuhashi. 1981. Purification and some properties of a cephalosporinase from Proteus vulgaris. Antimicrob. Agents Chemother. 19:185-187.
206. Matsumura, N., S. Minami, and S. Mitsuhashi. 1998. Sequences of homologous β-lactamases from clinical isolates of Serratia marcescens with different substrate specificities. Antimicrob. Agents Chemother. 42:176-179.
207. Matsuura, M., H. Nakazawa, M. Inoue, and S. Mitsuhashi. 1980. Purification and biochemical properties of β-lactamase produced by Proteus rettgeri. Antimicrob. Agents Chemother. 18:687-690.
208. Maurelli, A. T., R. E. Fernandez, C. A. Bloch, C. K. Rode, and A. Fasano. 1998. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coll. Proc. Natl. Acad. Sci. USA 95:3943-3948.
209. Michaux, C., J. Massant, F. Kerff, J. M. Frère, J. D. Docquier, I. Vandenberghe, B. Samyn, A. Pierrard, G. Feller, P. Charlier, J. Van Beeumen, and J. Wouters. 2008. Crystal structure of a cold-adapted class C β-lactamase. FEBS J. 275:1687-1697.
210. Migliavacca, R., E. Nucleo, M. M. D'Andrea, M. Spalla, T. Giani, and L. Pagani. 2007. Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities. New Microbiol. 30: 295-298.
211. Minami, S., M. Inoue, and S. Mitsuhashi. 1980. Purification and properties of a cephalosporinase from Enterobacter cloacae. Antimicrob. Agents Chemother. 18:853-857.
212. Minami, S., M. Inoue, and S. Mitsuhashi. 1980. Purification and properties of cephalosporinase in Escherichia coli. Antimicrob. Agents Chemother. 18:77-80.
213. Miriagou, V., P. T. Tassios, N. J. Legakis, and L. S. Tzouvelekis. 2004. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int. J. Antimicrob. Agents 23:547-555.
214. Miriagou, V., L. S. Tzouvelekis, L. Villa, E. Lebessí, A. C. Vatopoulos, A. Carattoli, and E. Tzelepi. 2004. CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid. Antimicrob. Agents Chemother. 48:3172-3174.
215. Mittal, S., S. Mallik, S. Sharma, and J. S. Virdi. 2007. Characteristics of β-lactamases and their genes (blaA and blaB) in Yersinia intermedia and Y. frederiksenii. BMC Microbiol. 7:25.
216. Moland, E. S., J. A. Black, J. Ourada, M. D. Reisbig, N. D. Hanson, and K. S. Thomson. 2002. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents Chemother. 46:3837-3842.
217. Moland, E. S., N. D. Hanson, J. A. Black, A. Hossain, W. Song, and K. S. Thomson. 2006. Prevalence of newer β-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J. Clin. Microbiol. 44:3318-3324.
218. Monnaie, D., and J. M. Frere. 1993. Interaction of clavulanate with class C β-lactamases. FEBS Lett. 334:269-271.
219. Moya, B., C. Juan, S. Albertí, J. L. Pérez, and A. Oliver. 2008. Benefit of having multiple ampD genes for acquiring β-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:3694-3700.
220. Moya, B., C. Juan, J. Blazquez, L. Zamorano, J. L. Perez, A. Oliver, and H. Son Dureta. 2008. Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-3729.
221. Mulvey, M. R., E. Bryce, D. A. Boyd, M. Ofner-Agostini, A. M. Land, A. E. Simor, and S. Paton. 2005. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49:358-365.
222. Murata, T., S. Minami, K. Yasuda, S. Iyobe, M. Inoue, and S. Mitsuhashi. 1981. Purification and properties of cephalosporinase from Pseudomonas aeruginosa. J. Antibiot. (Tokyo) 34:1164-1170.
223. M'Zali, F. H., J. Heritage, D. M. Gascoyne-Binzi, M. Denton, N. J. Todd, and P. M. Hawkey. 1997. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type β-lactamase exposed during an outbreak of SHV-5 extended-spectrum β-lactamase in a Leeds hospital. J. Antimicrob. Chemother. 40:823-831.
224. Naas, T., D. Aubert, N. Fortineau, and P. Nordmann. 2002. Cloning and sequencing of the β-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus. FEMS Microbiol. Lett. 215:81-87.
225. Naas, T., D. Aubert, A. Özean, and P. Nordmann. 2007. Chromosomeencoded narrow-spectrum Ambler class A β-lactamase GIL-1 from Citrobacter gillenii. Antimicrob. Agents Chemother. 51:1365-1372.
226. Naas, T., D. Aubert, S. Vimont, and P. Nordmann. 2004. Identification of a chromosome-borne class C β-lactamase from Erwinia rhapontici. J. Antimicrob. Chemother. 54:932-935.
227. Nadjar, D., R. Labia, C. Cerceau, C. Bizet, A. Philippon, and G. Arlet. 2001. Molecular characterization of chromosomal class C β-lactamase and its regulatory gene in Ochrobactrum anthropi. Antimicrob. Agents Chemother. 45:2324-2330.
228. Nadjar, D., M. Rouveau, C. Verdet, J. Donay, J. Herrmann, P. H. Lagrange, A. Philippon, and G. Arlet. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type β-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett. 187:35-40.
229. CMY-4 promoted by insertion sequence ISEcp1. J. Infect. Chemother. 13:18-23.
230. Nakano, R., R. Okamoto, Y. Nakano, K. Kaneko, N. Okitsu, Y. Hosaka, and M. Inoue. 2004. CFE-1, a novel plasmid-encoded AmpC β-lactamase with an ampR gene originating from Citrobacter freundii. Antimicrob. Agents Chemother. 48:1151-1158.
231. Nasim, K., S. Elsayed, J. D. Pitout, J. Conly, D. L. Church, and D. B. Gregson. 2004. New method for laboratory detection of AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae. J. Clin. Microbiol. 42: 4799-4802.
232. Navon-Venezia, S., A. Leavitt, and Y. Carmeli. 2007. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 59:772-774.
233. Neu, H. C., N. X. Chin, K. Jules, and P. Labthavikul. 1986. The activity of BMY 28142 a new broad spectrum β-lactamase stable cephalosporin. J. Antimicrob. Chemother. 17:441-452.
234. Nikaido, H., W. Liu, and E. Y. Rosenberg. 1990. Outer membrane permeability and β-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob. Agents Chemother. 34:337-342.
235. Niumsup, P., A. M. Simm, K. Nurmahomed, T. R. Walsh, P. M. Bennett, and M. B. Avison. 2003. Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of β-lactamase expression in Aeromonas spp. J. Antimicrob. Chemother. 51:1351-1358.
236. Nordmann, P., and H. Mammerí. 2007. Extended-spectrum cephalospori-nases: structure, detection and epidemiology. Future Microbiol. 2:297-307.
237. Nordström, K., L. G. Burman, and K. G. Eriksson-Grennberg. 1970. Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J. Bacteriol. 101:659-668.
238. Nukaga, M., S. Haruta, K, Tanimoto, K. Kogure, K. Taniguchi, M. Tamaki, and T. Sawai. 1995. Molecular evolution of a class C β-lactamase extending its substrate specificity. J. Biol. Chem. 270:5729-5735.
239. Odeh, R., S. Kelkar, A. M. Hujer, R. A. Bonomo, P. C. Schreckenberger, and J. P. Quinn. 2002. Broad resistance due to plasmid-mediated AmpC β-lactamases in clinical isolates of Escherichia coli. Clin. Infect. Dis. 35: 140-145.
240. Ogata, H., P. Renesto, S. Audic, C. Robert, G. Blanc, P. E. Fournier, H. Parinello, J. M. Claverie, and D. Raoult 2005. The genome sequence of Rickettsia fells identifies the first putative conjugative plasmid in an obligate intracellular parasite. PLoS Biol. 3:e248.
241. Ohana, S., V. Leflon, E. Ronco, M. Rottman, D. Guillemot, S. Lortat-Jacob, P. Denys, G. Loubert, M. H. Nicolas-Chanoine, J. L. Gaillard, and C. Lawrence. 2005. Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC β-lactamase in a teaching hospital admitting disabled patients. Antimicrob. Agents Chemother. 49:2095-2097.
242. Olsson, O., S. Bergström, F. P. Lindberg, and S. Normark. 1983. ampC β-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc. Natl. Acad. Sci. USA 80:7556-7560.
243. Olsson, O., S. Bergström, and S. Normark. 1982. Identification of a novel ampC β-lactamase promoter in a clinical isolate of Escherichia coli. EMBO J. 1:1411-1416.
244. PadilLa, E., D. Alonso, A. Doménech-Sa ́nchez, C. Gomez, J. L. Pérez, S. Albertí, and N. Borrell. 2006. Effect of porins and plasmid-mediated AmpC β-lactamases on the efficacy of β-lactams in rat pneumonia caused by Klebsiella pneumoniae. Antimicrob. Agents Chemother. 50:2258-2260.
245. Pai, H., C. I. Kang, J. H. Byeon, K. D. Lee, W. B. Park, H. B. Kim, E. C. Kim, M. D. Oh, and K. W. Choe. 2004. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:3720-3728.
246. Pai, H., J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh. 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 45:480-484.
247. Palasubramaniam, S., R. Karunakaran, G. G. Gin, S. Muniandy, and N. Parasakthi. 2007. lmipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction. Int. J. Infect. Dis. 11:472-474.
248. Papagiannitsis, C. C., L. S. Tzouvelekis, E. Tzelepi, and V, Miriagou. 2007. Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli. Antimicrob. Agents Chemother. 51:3763-3767.
249. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (M1R-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
250. ACC-1. Antimicrob. Agents Chemother. 51:2658-2659.
251. Pasteran, F. G., L. Otaegui, L. Guerriero, G. Radice, R. Maggiora, M. Rapoport, D. Faccone, A. Di Martino, and M. Galas. 2008. Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina. Emerg. Infect. Dis. 14:1178-1180.
252. Pérez-Pérez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
253. Petrella, S., D. Clermont, I. Casin, V. Jarlier, and W. Sougakoff. 2001. Novel class A β-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of β-lactamases within the Citrobacter genus. Antimicrob. Agents Chemother. 45:2287-2298.
254. Pfaller, M. A., R. N. Jones, S. A. Marshall, S. L. Coffman, R. J. Hollis, M. B. Edmond, and R. P. Wenzel. 1997. Inducible ampC β-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn. Microbiol. Infect. Dis. 28:211-219.
255. Philippon, A., G, Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
256. Pichardo, C., M. del Carmen Conejo, M. Bernabéu-Wittel, A. Pascual, M. E. Jiménez-Mejías, M. de Cueto, M. E. Pachón-Ibáñez, I. García, J. Pactión, and L. Martínez-Martínez. 2005. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 β-lactamase. Clin. Microbiol. Infect. 11: 31-38.
257. Pichardo, C., J. M. Rodríguez-Martínez, M. E. Pachón-Ibañez, C. Conejo, J. Ibáñez-Martínez, L. Martínez-Martínez, J. Pachón, and A. Pascual. 2005. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 β-lactamase. Antimicrob. Agents Chemother. 49:3311-3316.
258. Pitout, J. D., D. B. Gregson, D. L. Church, and K. B. Laupland. 2007. Population-based laboratory surveillance for AmpC β-lactamase- producing Escherichia coli, Calgary. Emerg. Infect. Dis. 13:443-448.
259. Pitout, J. D., E. S. Moland, C. C. Sanders, K. S. Thomson, and S. R. Fitzsimmons. 1997. β-Lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob. Agents Chemother. 41:35-39.
260. Pitout, J. D., M. D. Reisbig, M. Mulvey, L. Chui, M. Louie, L. Crowe, D. L. Church, S. Elsayed, D. Gregson, R. Ahmed, P. Tilley, and N. D. Hanson. 2003. Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC β-lactamase. CMY-2. J. Clin. Microbiol." 41:4578-4582.
261. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morgana clinical isolates. Antimicrob. Agents Chemother. 43: 769-776.
262. CTX-M in Escherichia coli. Antimicrob. Agents Chemother. 49:447-450.
263. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
264. Potz, N. A., R. Hope, M. Warner, A. P. Johnson, and D. M. Livermore. 2006. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J. Antimicrob. Chemother. 58: 320-326.
265. Power, P., M. Galleni, J. A. Ayala, and G. Gutkind. 2006. Biochemical and molecular characterization of three new variants of AmpC β-lactamases from Morganella morganii. Antimicrob. Agents Chemother. 50:962-967.
266. Powers, R. A., E. Caselli, P. J. Focia, F. Prati, and B. K. Shoichet. 2001. Structures of ceftazidime and its transition-state analogue in complex with AmpC β-lactamase: implications for resistance mutations and inhibitor design. Biochemistry 40:9207-9214.
267. Preston, K. E., C. C. Radomski, and R. A, Venezia. 2000. Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes Antimicrob. Agents Chemother. 44:3158-3162.
268. Qin, X., D, M. Zerrt, S. J. Weissman, J. A. Englund, D. M, Denno, E. J. Klein, P. I. Tarr, J. Kwong, J. R. Stapp, L. G. Tulloch, and E. Galanakis. 2008. Prevalence and mechanisms of broad-spectrum β-lactam resistance in Enterobacteriaceae: a children's hospital experience. Antimicrob. Agents Chemother. 52:3909-3914.
269. Quale, J., S. Bratu, J. Gupta, and D. Landman. 2006. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudo- monas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 50:1633-1641.
270. Queenan, A. M., S. Jenkins, and K. Bush. 2001. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded β-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob. Agents Chemother. 45:3189-3194.
271. Raimondi, A., A, Traverso, and H, Nikaido. 1991. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
272. Raskine, L., I. Borrel, G. Barnaud, S. Boyer, B. Hanau-Bercot, J. Gravisse, R. Labia, G. Arlet, and M. J. Sanson-Le-Pors. 2002. Novel plasmid-encoded class C β-lactamase (MOX-2) in Klebsiella pneumoniae from Greece. Antimicrob. Agents Chemother. 46:2262-2265.
273. Rasmussen, B. A., D. Keeney, Y. Yang, and K. Bush. 1994. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme. Antimicrob. Agents Chemother. 38:2078-2085.
274. Recchia, G. D., and R. M. Hall. 1995. Gene cassettes: a new class of mobile element. Microbiology 141:3015-3027.
275. Reisbig, M. D., and N. D. Hanson. 2002. The ACT-1 plasmid-encoded AmpC β-lactamase is inducible: detection in a complex β-lactamase background. J. Antimicrob. Chemother. 49:557-560.
276. MIR-1. Antimicrob. Agents Chemother. 48:4177-4182.
277. Reisbig, M, D., A. Hossain, and N. D. Hanson. 2003. Factors influencing gene expression and resistance for gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin. J. Antimicrob. Chemother. 51:1141-1151.
278. Robin, F., J. Delmas, M. Archambaud, C. Schweitzer, C. Chanal, and R. Bonnet. 2006. CMT-type β-lactamase TEM-125, an emerging problem for extended-spectrum β-lactamase detection. Antimicrob. Agents Chemother. 50:2403-2408.
279. Rogers, M. B., A. C. Parker, and C. J. Smith. 1993. Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A β-lactamases. Antimicrob. Agents Chemother. 37:2391-2400.
280. Rottman, M., Y. Benzerara, B. Hanau-Bercot, C. Bizet, A. Philippon, and G. Arlet. 2002. Chromosomal ampC genes in Enterobacter species other than Enterobacter cloacae, and ancestral association of the ACT-1 plasmid-encoded cephalosporinase to Enterobacter asburiae. FEMS Microbiol. Lett. 210:87-92.
281. Ruppé, E., P. Bidet, C. Verdet, G. Arlet, and E. Bingen. 2006. First detection of the Ambler class C 1 AmpC β-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J. Clin. Microbiol. 44:4204-4207.
282. Sabath, L. D., M. Jago, and E. P. Abraham. 1965. Cephalosporinase and penicillinase activities of a β-lactamase from Pseudomonaspyocyanea. Biochem. J. 96:739-752.
283. Sader, H. S., R. N. Jones, M. G. Stilwell, M. J. Dowzicky, and T. R. Fritsche. 2005. Tigecycline activity tested against 26.474 bloodstream infection isolates: a collection from 6 continents. Diagn. Microbiol. Infect. Dis. 52:181-186.
284. Sanders, C. C. 1993. Cefepime: the next generation? Clin. Infect. Dis. 17:369-379.
285. Reference deleted.
286. Sanders, C. C., and W. E. Sanders, Jr. 1986. Type I β-lactamases of gram-negative bacteria: interaction with β-lactam antibiotics. J. Infect. Dis. 154:792-800.
287. Sanders, W. E., Jr., J. H. Tenney, and R. E. Kessler. 1996. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin. Infect. Dis. 23:454-461.
288. Sawai, T., A. Yamaguchi, and K. Tsukamoto. 1988. Amino acid sequence, active-site residue, and effect of suicide inhibitors on cephalosporinase of Citrobacter freundii GN346. Rev. Infect. Dis. 10:721-725.
289. Schiefer, A. M., I. Wiegand, K. J. Sherwood, B. Wiedemann, and I. Stock. 2005. Biochemical and genetic characterization of the β-lactamases of Y. aldovae, Y. bercovieri. Y frederiksenii and "Y. ruckeri" strains. Int. J. Antimicrob. Agents 25:496-500.
290. Schmidtke, A. J., and N. D. Hanson. 2006. Model system to evaluate the effect of ampD mutations on AmpC-mediated β-lactam resistance. Antimicrob. Agents Chemother. 50:2030-2037.
291. Schmidtke, A. J., and N. D. Hanson. 2008. Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aemginosa. Antimicrob. Agents Chemother. 52:3922-3927.
292. Schumacher, H., M. Nir, B. Mansa, and A. Grassy. 1992. β-Lactamases in Shigella. APMIS 100:954-956.
293. Segal, H., E. C. Nelson, and B. G. Elisha. 2004. Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob. Agents Chemother. 48:612-614.
294. Seoane, A., M. V. Francia, and J. M. Garcia Lobo. 1992. Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica. Antimicrob. Agents Chemother. 36:1049-1052.
295. Seoane, A., and J. M. Garcia Lobo. 1991. Cloning of chromosomal β-lactamase genes from Yersinia enterocolitis. J. Gen. Microbiol. 137:141-146.
296. Shahid, M., A. Malik, M. Agrawal, and S. Singhal. 2004. Phenotypic detection of extended-spectrum and AmpC β-lactamases by a new spotinoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test. J. Antimicrob. Chemother. 54:684-687.
297. Sharma, S., P. Ramnani, and J. S. Virdi. 2004. Detection and assay of β-lactamases in clinical and non-clinical strains of Yersinia enterocolitica biovar 1A. J. Antimicrob. Chemother. 54:401-405.
298. Siu, L. K., P. L. Lu, J. Y. Chen, F. M. Lin, and S. C. Chang. 2003. High-level expression of ampC β-lactamase due to insertion of nucleotides between - 10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-speetrum-cephalosporin treatment. Antimicrob. Agents Chemother. 47:2138-2144.
299. Smith, C. J., T. K. Bennett, and A. C. Parker. 1994. Molecular and genetic analysis of the Racteroides unifonnis cephalosporinase gene, cblA, encoding the species-specific β-lactamase. Antimicrob. Agents Chemother. 38:1711-1715.
300. Sohn, S. G., J. J. Lee, E. S. Sohn, L. W. Kang, and S. H. Lee. 2008. Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J. Antimicrob. Chemother. 61:965-966.
301. Song, W., I. K. Bae, Y. N. Lee, C. H, Lee, S. H. Lee, and S. H. Jeong. 2007. Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J. Clin. Microbiol. 45:1180-1184.
302. Song, W., S. H. Jeong, J. S. Kim, H. S. Kim, D. H. Shin, K. H. Roh, and K. M, Lee, 2007. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn. Microbiol. Infect. Dis. 57:315-318.
303. Stapleton, P., K. Shannon, and L Phillips. 1995. The ability of β-lactam antibiotics to select mutants with derepressed β-lactamase synthesis from Citrobacter freundii. J. Antimicrob. Chemother. 36:483-496.
304. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
305. Steward, C. D., J. K. Rasheed, S. K. Hubert, J. W. Biddle, P. M. Raney, G. J. Anderson, P. P. Williams, K. L. Brittain, A. Oliver, J. E. McGowan, Jr., and F. C. Tenover. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. J. Clin. Microbiol. 39:2864-2872.
306. Stock, I. 2005. Natural antimicrobial susceptibility patterns of Kluyvera ascorbata and Kluyvera ayocrescens strains and review of the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections. J. Chemother. 17:143-160.
307. Stock, I., S. Burak, K. J. Sherwood, T. Gruger, and B. Wiedemann. 2003. Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea. J. Antimicrob. Chemother. 51:865-885.
308. Stock, I., T. Grueger, and B. Wiedemann. 2003. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. Int. J. Antimicrob. Agents 22:35-47.
309. Stock, I., T. Grüger, and B. Wiedemann. 2000. Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains. J. Chemother. 12:30-39.
310. Stock, I., B. Henrichfreise, and B. Wiedemann. 2002. Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica -like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and 'Y. ruckeri.' J. Med. Microbiol. 51:56-69.
311. Stock, I., M. Rahman, K. J. Sherwood, and B. Wiedemann. 2005. Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains. Diagn. Microbiol. Infect. Dis. 51: 151-163.
312. Stock, I., K. J. Sherwood, and B. Wiedemann. 2003. Natural antibiotic susceptibility of Ewingella americana strains. J. Chemother. 15:428-441.
313. Stock, I., and B. Wiedemann, 2001. Natural antibiotic susceptibilities of Edwardsiella tarda. E. ictaluii, and E. hoshinae. Antimicrob. Agents Chemother. 45:2245-2255.
314. Stock, I., and B. Wiedemann. 2003. Natural antimicrobial susceptibilities and biochemical profiles of Yersinia enterocolitica-like strains: Y. frederiksenii. Y. intermedia, Y. kristensenii and Y. rohdei. FEMS Immunol. Med. Microbiol. 38:139-152.
315. Su, L. H., T. L. Wu, J. H. Chia, C. Chu, A. J. Kuo, and C. H. Chiu. 2005. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 55:846-852.
316. Tan, T. Y., S. Y. Ng, L. Teo, Y. Koh, and C. H. Teok. 2008. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. J. Clin. Pathol. 61:642-644.
317. Then, R. L., and P. Angehrn. 1982. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. Antimicrob. Agents Chemother. 21:711-717.
318. Thiolas, A., C. Bollet, B. La Scola, D. Raoult, and J. M. Pagès. 2005. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob. Agents Chemother. 49:1354-1358.
319. Thomson, K. S. 2001. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg. Infect. Dis. 7:333-336.
320. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877-1882.
321. Thomson, K. S., C. C. Sanders, and J. A. Washington II. 1993. Ceftazidime resistance in Hafnia alvei. Antimicrob. Agents Chemother. 37:1375-1376.
322. Tokunaga, H., M. Ishibashi, T. Arakawa, and M. Tokunaga. 2004. Highly efficient renaturation of β-lactamase isolated from moderately halophilic bacteria. FEBS Lett. 558:7-12.
323. Toleman, M. A., P. M. Bennett, and T. R. Walsh. 2006. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70:296-316.
324. Tracz, D. M., D. A. Boyd, R. Hizon, E. Bryce, A. McGeer, M. Ofner-Agostini, A. E. Simor, S. Paton, and M. R. Mulvey. 2007. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett. 270:265-271.
325. Tsakris, A., I. Kristo, A. Poulou, F. Markou, A. Ikonomidis, and S. Pournaras. 2008. First occurrence of KPC-2-possesing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J. Antimicrob. Chemother. 62:1257-1260.
326. Tzouvelekis, L. S., E. Tzelepi, M. E. Kaufmann, and A. F. Mentis. 1994. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J. Med. Microbiol. 40:403-407.
327. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, and A. Tsakris. 1993. Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J. Antimicrob. Chemother. 31:645-654.
328. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, A. C. Vatopoulos, and A. Tsakris. 1992. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability. FEMS Microbiol. Lett. 74:195-199.
329. Underwood, S., and M. B. Avison. 2004. Citrobacter koseri and Citrobacter amalonaticus isolates cany highly divergent β-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology. J. Antimicrob. Chemother. 53:1076-1080.
330. Vimont, S., D. Aubert, J. X. Mazoit, L. Poirel, and P. Nordmann. 2007. Broad-spectrum β-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases. J. Antimicrob. Chemother. 60:1045-1050.
331. Vu, H., and H. Nikaido. 1985. Role of β-lactam hydrolysis in the mechanism of resistance of a β-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum β-lactams. Antimicrob. Agents Chemother. 27:393-398.
332. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa, 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A β-lactamase, GES-4. possessing a single G170S substitution in the Ω-loop. Antimicrob. Agents Chemother. 48: 2905-2910.
333. CMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50:534-541.
334. Walsh, T. R., L. Hall, A. P. MacGowan, and P. M. Bennett. 1995. Sequence analysis of two chromosomally mediated inducible β-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase. J. Antimicrob. Chemother. 36:41-52.
335. Walsh, T. R., R. A. Stunt, J. A. Nabi, A. P. MacGowan, and P. M. Bennett. 1997. Distribution and expression of β-lactamase genes among Aeromonas spp. J. Antimicrob. Chemother. 40:171-178.
336. Walther-Rasmussen, J., and N. Høiby. 2002. Plasmid-borne AmpC β-lactamases. Can. J. Microbiol. 48:479-493.
337. Weber, D. A., and C. C. Sanders. 1990. Diverse potential of β-lactamase inhibitors to induce class I enzymes. Antimicrob. Agents Chemother. 34: 156-158.
338. Weng, S. F., Y. F. Chao, and J. W. Lin. 2004. Identification and characteristic analysis of the ampC gene encoding β-lactamase from Vibrio fischeri. Biochem. Biophys. Res. Commun. 314:838-843.
339. Whichard, J., K. Gay, J. E. Stevenson, K. Joyce, K. Cooper, M. Omondi, M. F., G. A. Jacoby, and T. J. Barrett. 2007. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg. Infect. Dis. 13:1681-1688.
340. Whichard, J. M., K. Joyce, P. D. Fey, J. M. Nelson, F. J. Angulo, and T. J. Barrett 2005. β-Lactam resistance and Enterobacteriaceae, United States. Emerg. Infect. Dis. 11:1464-1466.
341. Winokur, P. L., A. Brueggemann, D. L. DeSalvo, L. Hoffmann, M. D. Apley, E. K. Uhlenhopp, M. A. Pfaller, and G. V. Doern. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrob. Agents Chemother. 44:2777-2783.
342. Wong-Beringer, A., J. Hindler, M. Loeloff, A. M. Queenan, N. Lee, D. A. Pegues, J. P. Quinn, and K. Bush. 2002. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clin. Infect. Dis. 34:135-146.
343. Woodford, N., S. Reddy, E. J. Fagan, R. L. Hill, K. L. Hopkins, M. E. Kaufmann, J. Kistler, M. F. Palepou, R. Pike, M. E. Ward, J. Cheesbrough, and D. M. Livermore. 2007. Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J. Antimicrob. Chemother. 59:102-105.
344. Wu, S. W., K. Dornbusch, G. Kronvall, and M. Norgren. 1999. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type β-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC β-lactamase. Antimicrob. Agents Chemother. 43:1350-1357.
345. Yagi, T., J. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, Y. Doi, N. Shibata, H. Kato, K. Shibayama, and Y. Arakawa. 2005. Practical methods using boronic acid compounds for identification of class C β-lactamase -producing Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 43:2551-2558.
346. Yan, J. J., P. R. Hsueh, J. J. Lu, F. Y. Chang, J. M. Shyr, J. H. Wan, Y. C. Liu, Y. C. Chuang, Y. C. Yang, S. M. Tsao, H. H. Wu, L. S. Wang, T. P. Lin, H. M. Wu, H. M. Chen, and J. J. Wu. 2006. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob. Agents Chemother. 50:1861-1864.
347. Yan, J. J., W. C. Ko, H. M. Wu, S. H. Tsai, C. L. Chuang, and J. J. Wu. 2004. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectmm cephalosporins at a teaching hospital in Taiwan. J. Clin. Microbiol. 42:5337-5340.
348. Yan, J. J., W. C. Ko, J. J. Wu, S. H. Tsai, and C. L. Chuang. 2004. Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital. J. Clin. Microbiol. 42:3329-3332.
349. Yatsuyanagi, J., S. Saito, T. Konno, S. Harata, N. Suzuki, J. Kato, and K. Amano. 2006. Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution. Jpn. J. Infect. Dis. 59:153-159.
350. Yigit, H., G. J. Anderson, J. W. Biddle, C. D. Steward, J. K. Rasheed, L. L. Valera, J. E. McGowan, Jr., and F. C. Tenover. 2002. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpE and OmpC porin analogs. Antimicrob. Agents Chemother. 46:3817-3822.
351. Zanetti, G., F. Bally, G. Greub, J. Garbino, T. Kinge, D. Lew, J. A. Romand, J. Bille, D. Aymon, L. Stratchounski, L. Krawczyk, E. Rubinstein, M. D. Schaller, R. Chiolero, M. P. Glauser, and A. Cometta. 2003. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob. Agents Chemother. 47:3442-3447.
352. Zhu, L. X., Z. W. Zhang, D. Liang, D. Jiang, C. Wang, N. Du, Q. Zhang, K. Mitchelson, and J. Cheng. 2007. Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob. Agents Chemother. 51:3707-3713.